Kevin Kim

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Bristol Myers Squibb
    Topic: 
    melanoma
    Date added: 
    05/03/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    12/31/2023
    Date reviewed: 
    07/27/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Regeneron/ Sanofi
    Topic: 
    skin cancer
    Date added: 
    05/03/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    12/31/2022
    Date reviewed: 
    07/27/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Bristol Myers Squibb
    Topic: 
    melanoma
    Date added: 
    05/03/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    12/31/2022
    Date reviewed: 
    07/27/2023
Return to 0102_SHVGR_Melanoma Trends and Medical Advances_Live